The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Description

Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

Conditions

Healthy Aging, Healthy, Healthy Diet

Talk to us

Study Overview

On this page

Study Details

Study overview

Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

Open-labelled Study to Validate Home-based Use of a Health and Wellness Kit (The Mitopure Challenge) to Detect Levels of Urolithin A in Dried Blood Spots After Intake of Mitopure (Proprietary Urolithin A)

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Condition
Healthy Aging
Intervention / Treatment

-

Contacts and Locations

San Francisco

Amazentis USA, San Francisco, California, United States, 94111

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Males and females 18 to 80 years of age;
  • 2. Is in general good health, as determined by the research team;
  • 3. Willingness to consume the investigation product, complete questionnaires and to complete the study;
  • 4. Have given voluntary, electronic, informed consent to be a participant in the study.
  • 1. Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial;
  • 2. Volunteers who plan to donate blood during the study or within 30 days of completing the study;
  • 3. Subject has a known allergy to the test material's active or inactive ingredients;
  • 4. Subjects with unstable medical conditions;
  • 5. Participation in a clinical research trial within 30 days prior to randomization;
  • 6. Allergy or sensitivity to study ingredients;
  • 7. Individuals who are cognitively impaired and/or who are unable to give informed consent;
  • 8. Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject;
  • 9. Has taken antibiotics within the previous 30 days.

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Amazentis SA,

Anurag Singh, MD, PhD, PRINCIPAL_INVESTIGATOR, Amazentis SA

Study Record Dates

2025-08-31